Nanobiofab
NanoBioFAB is a leading provider of high-throughput technology and services that accelerate nanomaterial research and development. The company offers patented nano inkjet printing and screening robots capable of producing and testing up to one million nanomaterial trials per day, enabling cost-effective innovation and faster time to market for new sensor products. Their technology supports the development of AI-driven smart sensors for telemedicine and personalized healthcare, detecting gases from skin and breath and measuring environmental factors like pressure, temperature, and humidity. Validated by CalTech and supported by a team of experts in materials science, sensor engineering, and software, NanoBioFAB empowers customers to stay competitive in the emerging 5G era with advanced personal health management solutions.
Nanobiofab
NanoBioFAB is a leading provider of high-throughput technology and services that accelerate nanomaterial research and development. The company offers patented nano inkjet printing and screening robots capable of producing and testing up to one million nanomaterial trials per day, enabling cost-effective innovation and faster time to market for new sensor products. Their technology supports the development of AI-driven smart sensors for telemedicine and personalized healthcare, detecting gases from skin and breath and measuring environmental factors like pressure, temperature, and humidity. Validated by CalTech and supported by a team of experts in materials science, sensor engineering, and software, NanoBioFAB empowers customers to stay competitive in the emerging 5G era with advanced personal health management solutions.
TL;DR
Founded: 2016
HQ: Frederick, Maryland
Core tech: AI-integrated high-throughput 3D nano-printing and nanosensor screening
Use cases: Wearable/compact nanosensors for pathogen and health monitoring (breath/skin gas detection)
Funding signal: TEDCO investor / multiple TEDCO grants; MedTech Innovator support
Company Overview
Problem Domain
Accelerating nanomaterial R&D and commercializing nanosensor devices for real-time health and environmental monitoring.
Founded
2016
Industry
Biotechnology
Funding Track Record
Most recently disclosed round listed as Pre-Seed (amount obfuscated in sources)
TEDCO pre-seed investment / award announced July 2018
Investor Signal
“TEDCO as primary investor/funder across multiple pre-seed rounds and grants; MedTech Innovator as supporter/non-equity provider”